SCHEMBL1147477

SCHEMBL1147477

CCOC(=O)C1CCC(O)(C#Cc2cccc3ncc(OC)cc23)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 4/20 0.45
MTNR1B P49286 6/20 0.44
MTNR1A P48039 5/20 0.44
MAPT P10636 5/20 0.44
ALDH1A1 P00352 7/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
NPSR1 Q6W5P4 2/20 0.41
TAAR1 Q96RJ0 1/20 0.41
KDM4E B2RXH2 3/20 0.41
HTT P42858 3/20 0.39
HPGD P15428 2/20 0.39
MAPK1 P28482 2/20 0.39
GAA P10253 1/20 0.39
TSHR P16473 1/20 0.39
CASP1 P29466 1/20 0.39
HSD17B10 Q99714 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1147475 1.00 TP53 (0.45) TP53MTNR1BMTNR1AMAPTALDH1A1
SCHEMBL1147474 1.00 TP53 (0.45) TP53MTNR1BMTNR1AMAPTALDH1A1
SCHEMBL1147473 0.86 ALDH1A1 (0.48) TP53MTNR1BMTNR1AMAPTALDH1A1
SCHEMBL1147472 0.86 ALDH1A1 (0.48) TP53MTNR1BMTNR1AMAPTALDH1A1
SCHEMBL1147471 0.86 ALDH1A1 (0.48) TP53MTNR1BMTNR1AMAPTALDH1A1
SCHEMBL1148119 0.79 MTNR1B (0.56) TP53MTNR1BMTNR1AMAPTALDH1A1
SCHEMBL1148121 0.79 MTNR1B (0.56) TP53MTNR1BMTNR1AMAPTALDH1A1
SCHEMBL1148117 0.79 MTNR1B (0.56) TP53MTNR1BMTNR1AMAPTALDH1A1
SCHEMBL1148210 0.72 KCNH2 (0.39) TP53MAPTALDH1A1MEN1KMT2A
SCHEMBL1148213 0.72 KCNH2 (0.39) TP53MAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7888359-B2 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives ACTELION PHARMACEUTICAL LTD. (CH) 2011-02-15 US disclosed
EP-2001478-B1 CYCLOHEXYL OR PIPERIDINYL CARBOXAMIDE ANTIBIOTIC DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2010-06-02 EP disclosed
US-20090105232-A1 CYCLOHEXYL OR PIPERIDINYL CARBOXAMIDE ANTIBIOTIC DERIVATIVES ACTELION PHARMACEUTICALS LTD. (CH) 2009-04-23 US disclosed
EP-2001478-A1 CYCLOHEXYL OR PIPERIDINYL CARBOXAMIDE ANTIBIOTIC DERIVATIVES Actelion Pharmaceuticals Ltd. (CH) 2008-12-17 EP disclosed
WO-2007107965-A1 CYCLOHEXYL OR PIPERIDINYL CARBOXAMIDE ANTIBIOTIC DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2007-09-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105232-A1 CYCLOHEXYL OR PIPERIDINYL CARBOXAMIDE ANTIBIOTIC DERIVATIVES CBR3, RXFP4, ODC1 TP53 4315/4885MTNR1B 1457/4885MTNR1A 1051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.